Author

Emanuel Engmann

Observed name: E Engmann

Institution: Ipsen (United Kingdom)

Observed institutions: Ipsen (France), Ipsen (United Kingdom)

ORCID: 0009-0008-5288-4289

Observed ORCID: 0009-0008-5288-4289

OpenAlex ID: A5076346865

A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity

2023 · Clive Bezzina, Vadim Degtiar, et al. · Toxins · 2

Clinical and Economic Outcomes of Adult Limb Spasticity Treatment with Botulinum Toxin Type A Products: A Single-Center, Non-Interventional Study

2022 · Clive Bezzina, Vadim Degtiar, et al. · Toxicon

CO6 Clinical and Economic Outcomes of Adult Limb Spasticity Treatment with Botulinum Toxin-a (BONT-A) Products: A Single-Center Non-Interventional Retrospective Study

2022 · C Bezzina, V Degtiar, et al. · Value in Health

Works count: 3

Citation count: 2

H-index: 1

I10-index: